Last Updated:
Name Designation Appointment Date Status
Sanjeev Indravadan Dani

Appointed as Director since July 2005

 Director 28-Jul-2005 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Rexcel Pharmaceuticals Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Ashwani Kumar Malhotra

Appointed as Nominee Director since November 2010

 Nominee Director 01-Nov-2010 Current
Ranjit Kohli

Appointed as Director since March 2012

 Director 12-Mar-2012 Current
Sandeep Mehandroo

Appointed as Director since January 2008

 Director 30-Jan-2008 Current

People Timeline

Explore the timeline of key personnel in Rexcel Pharmaceuticals Limited's leadership journey.

Contact Details
  • Address 12Th Floor, Devika Tower, Nehru Place, New Delhi Delhi, 110019, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110019
  • Country India
  • Website -
Frequently Asked Questions
You can contact Rexcel Pharmaceuticals Limited through their registered address at 12Th Floor, Devika Tower, Nehru Place, New Delhi Delhi, 110019, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Rexcel Pharmaceuticals Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SANJEEV INDRAVADAN DANI
  • ASHWANI KUMAR MALHOTRA
  • RANJIT KOHLI
  • SANDEEP MEHANDROO
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available